# Eric Goupil

> Eric Goupil is a seed investor at Unither Pharmaceuticals backing Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Unither Pharmaceuticals](https://shizune.co/investors/profile/unither-pharmaceuticals)
- Total investments: 1
- Last investment: Jun 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/eric-goupil-3b526b/

Eric Goupil is a seed investor at Unither Pharmaceuticals focused on Health Care and Biotechnology. Eric Goupil, CEO of Unither Pharmaceuticals, discusses the company’s development strategy moving forward after the completion of a leveraged buyout in 2017. Additionally, Goupil shares the CDMO’s innovation capabilities as a leading player in the Blow-fill-seal (BFS) niche.

## Contacts

5 contacts available for Eric Goupil: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/eric-goupil-93d7?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| BIOPHTA | BIOPHTA has pioneered a new approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery. Their non-invasive topical ocular inserts represent a significant advancement in the treatment of many ophthalmic disorders, providing superior long-term disease management. | $7.1M | Seed | Jun 03, 2024 |  |

1 of 1 investments shown.

## Co-investors
- [Elaia](https://shizune.co/investors/profile/elaia-partners) — VC Fund, 1 deal together
- [HTL Biotechnology](https://shizune.co/investors/profile/htl) — VC Fund, 1 deal together
- [GO CAPITAL](https://shizune.co/investors/profile/ouest-ventures) — VC Fund, 1 deal together
- [UI Investissement](https://shizune.co/investors/profile/ui-gestion) — VC Fund, 1 deal together

## About Unither Pharmaceuticals

VC Fund · Paris, France

Unither Pharmaceuticals is a French manufacturer of dosage forms for pharmaceutical laboratories, and generic products. The world leader in the contract manufacturing of pharmaceutical products.

2 contacts available at Unither Pharmaceuticals.

| Name | Title | Profile |
| --- | --- | --- |
| Alexandre Rochereau | Chief Information Officer | https://shizune.co/investors/profile/alexandre-rochereau-3e59 |
| Eric Goupil | CEO | https://shizune.co/investors/profile/eric-goupil-93d7 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Eric Goupil invest in?

Eric Goupil invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Eric Goupil?

Public channels for Eric Goupil include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Eric Goupil last invest?

The most recent investment recorded for Eric Goupil closed in Jun 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co